Sanne van Wissen

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial

TJ Smilde, Sanne van Wissen, H Awollersheim et al. · The Lancet · 2001 · 922 citations

Medicine, Cardiology, Preventive Cardiology +13

Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors

Truman J. Milling, Saskia Middeldorp, Lizhen Xu et al. · Circulation · 2023 · 152 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy

Sanne van Wissen, Mieke D. Trip, Tineke J. Smilde et al. · Atherosclerosis · 2002 · 115 citations

Pharmacy, Cardiology, Pharmacotherapy +9

Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy

Anne Grete Semb, Sanne van Wissen, Thor Ueland et al. · Journal of the American College of Cardiology · 2003 · 112 citations

Medicine, Cardiology, Immunology +10

Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial

Arina J. ten Cate‐Hoek, Elham E Amin, A.C. Bouman et al. · The Lancet Haematology · 2017 · 98 citations · Full text

Medicine, Surgery, Vascular Surgery +5